Saint Kitts and Nevis vs Saint Lucia: Hepatitis B surface antigen (HBsAg) prevalence
Saint Kitts and Nevis
0.2%
in 2024
Saint Lucia
0.2%
in 2024
Saint Kitts and Nevis rank
82nd
Saint Lucia rank
82nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Saint Kitts and Nevis
- Saint Lucia
How they compare
Saint Kitts and Nevis currently reports 0.2% against 0.2% in Saint Lucia, a difference of 0.0%.
Across all 10 years both countries report, Saint Lucia has been ahead every year.
Saint Kitts and Nevis ranks 82nd and Saint Lucia ranks 82nd of 194 countries.
Head to head by decade
| Decade | Saint Kitts and Nevis | Saint Lucia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.0% | — |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Saint Kitts and Nevis or Saint Lucia?
- Saint Kitts and Nevis, at 0.2% against 0.2% in Saint Lucia as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Saint Kitts and Nevis and Saint Lucia?
- 0.0%, with Saint Kitts and Nevis ahead.
- How many years of comparable data are there for Saint Kitts and Nevis and Saint Lucia?
- 10 years are reported by both, from 2015 to 2024.
- How do Saint Kitts and Nevis and Saint Lucia rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Saint Kitts and Nevis ranks 82nd and Saint Lucia ranks 82nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.